Titan Biotech Ltd — Dividend/Bonus, 29-11-2025: Corp. Action

Titan Biotech's board has approved a 1-for-5 equity share split, changing each share with a face value of Rs. 10 into five shares with a face value of Rs. 2. This strategic decision aims to enhance the shares' liquidity and broaden retail investor participation by making the equity more accessible. The company’s authorized share capital will remain Rs. 10 Crore, while the number of shares will increase accordingly. This proposal awaits shareholder approval via postal ballot and is expected to be completed within two months after the approval.